DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Tesaglitazar is an investigational drug.
There have been 17 clinical trials for Tesaglitazar. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2004.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Insulin Resistance. The leading clinical trial sponsors are AstraZeneca and [disabled in preview].
Recent Clinical Trials for Tesaglitazar
|GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes||AstraZeneca||Phase 3|
|ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity||AstraZeneca||Phase 2|
|GALLANT 22 Tesaglitazar vs. Placebo||AstraZeneca||Phase 3|